Rapid Therapeutic Science Stock Market Value
| RTSL Stock | USD 0 0.00 0.00% |
| Symbol | Rapid |
Rapid Therapeutic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rapid Therapeutic's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rapid Therapeutic.
| 11/10/2024 |
| 01/09/2025 |
If you would invest 0.00 in Rapid Therapeutic on November 10, 2024 and sell it all today you would earn a total of 0.00 from holding Rapid Therapeutic Science or generate 0.0% return on investment in Rapid Therapeutic over 60 days. Rapid Therapeutic is related to or competes with InspireMD, Bluejay Diagnostics, Movano, EnVVeno Medical, Alphatec Holdings, Axogen, and Delcath Systems. Rapid Therapeutic Science Laboratories, Inc More
Rapid Therapeutic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rapid Therapeutic's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rapid Therapeutic Science upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.055 | |||
| Maximum Drawdown | 100.0 |
Rapid Therapeutic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rapid Therapeutic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rapid Therapeutic's standard deviation. In reality, there are many statistical measures that can use Rapid Therapeutic historical prices to predict the future Rapid Therapeutic's volatility.| Risk Adjusted Performance | 0.0548 | |||
| Jensen Alpha | 0.7044 | |||
| Total Risk Alpha | 0.493 | |||
| Treynor Ratio | 0.1346 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rapid Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Rapid Therapeutic Science Backtested Returns
Rapid Therapeutic appears to be out of control, given 3 months investment horizon. Rapid Therapeutic Science maintains Sharpe Ratio (i.e., Efficiency) of 0.0569, which implies the firm had a 0.0569% return per unit of risk over the last 3 months. By analyzing Rapid Therapeutic's technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please evaluate Rapid Therapeutic's Coefficient Of Variation of 1758.03, variance of 207.65, and Risk Adjusted Performance of 0.0548 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Rapid Therapeutic holds a performance score of 4. The company holds a Beta of 6.01, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Rapid Therapeutic will likely underperform. Please check Rapid Therapeutic's treynor ratio and day median price , to make a quick decision on whether Rapid Therapeutic's historical price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Rapid Therapeutic Science has no correlation between past and present. Overlapping area represents the amount of predictability between Rapid Therapeutic time series from 10th of November 2024 to 10th of December 2024 and 10th of December 2024 to 9th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rapid Therapeutic Science price movement. The serial correlation of 0.0 indicates that just 0.0% of current Rapid Therapeutic price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Rapid Therapeutic Science lagged returns against current returns
Autocorrelation, which is Rapid Therapeutic pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Rapid Therapeutic's pink sheet expected returns. We can calculate the autocorrelation of Rapid Therapeutic returns to help us make a trade decision. For example, suppose you find that Rapid Therapeutic has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Rapid Therapeutic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Rapid Therapeutic pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Rapid Therapeutic pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Rapid Therapeutic pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Rapid Therapeutic Lagged Returns
When evaluating Rapid Therapeutic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Rapid Therapeutic pink sheet have on its future price. Rapid Therapeutic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Rapid Therapeutic autocorrelation shows the relationship between Rapid Therapeutic pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Rapid Therapeutic Science.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Rapid Pink Sheet
Rapid Therapeutic financial ratios help investors to determine whether Rapid Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rapid with respect to the benefits of owning Rapid Therapeutic security.